Literature DB >> 17008944

Aortic occlusion in patients treated with Cisplatin-based chemotherapy.

Tal Grenader1, Linda Shavit, Inna Ospovat, Orit Gutfeld, Tamar Peretz.   

Abstract

Cisplatin-based chemotherapy is one of the most common chemotherapy regimens that is complicated by thromboembolic events. A wide spectrum of vascular events exists, including venous and arterial thromboses of varying severity and location. However, total occlusion of the aorta is very unusual. We describe two patients with atherosclerotic vascular disease who developed occlusion of the abdominal aorta after cisplatin-based chemotherapy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17008944

Source DB:  PubMed          Journal:  Mt Sinai J Med        ISSN: 0027-2507


  7 in total

Review 1.  What the emergency radiologist needs to know about treatment-related complications from conventional chemotherapy and newer molecular targeted agents.

Authors:  Sona A Chikarmane; Bharti Khurana; Katherine M Krajewski; Atul B Shinagare; Stephanie Howard; Aaron Sodickson; Jyothi Jagannathan; Nikhil Ramaiya
Journal:  Emerg Radiol       Date:  2012-06-07

2.  High incidence of thromboembolic events in patients treated with cisplatin-based chemotherapy: a large retrospective analysis.

Authors:  Russell A Moore; Nelly Adel; Elyn Riedel; Manisha Bhutani; Darren R Feldman; Nour Elise Tabbara; Gerald Soff; Rekha Parameswaran; Hani Hassoun
Journal:  J Clin Oncol       Date:  2011-08-01       Impact factor: 44.544

3.  Effects of cisplatin on the contractile function of thoracic aorta of Sprague-Dawley rats.

Authors:  Ying Jiang; Shigang Shan; Tieer Gan; Xiaoyun Zhang; Xianghong Lu; Hu Hu; Yihua Wu; Jianzhong Sheng; Jun Yang
Journal:  Biomed Rep       Date:  2014-08-19

4.  Arterial occlusion precipitated by cisplatinbased chemotherapy.

Authors:  D Joseph; B Dubashi; B Karthikeyan; A Jain
Journal:  Curr Oncol       Date:  2010-11       Impact factor: 3.677

5.  Acute aortic thrombosis in patients receiving cisplatin-based chemotherapy.

Authors:  D D Fernandes; M L Louzada; C A Souza; F Matzinger
Journal:  Curr Oncol       Date:  2011-04       Impact factor: 3.677

6.  The high incidence of vascular thromboembolic events in patients with metastatic or unresectable urothelial cancer treated with platinum chemotherapy agents.

Authors:  Christopher M Tully; Andrea B Apolo; Emily C Zabor; Ashley M Regazzi; Irina Ostrovnaya; Helena F Furberg; Jonathan E Rosenberg; Dean F Bajorin
Journal:  Cancer       Date:  2015-11-30       Impact factor: 6.860

Review 7.  Vascular Toxicities of Cancer Therapies: The Old and the New--An Evolving Avenue.

Authors:  Joerg Herrmann; Eric H Yang; Cezar A Iliescu; Mehmet Cilingiroglu; Konstantinos Charitakis; Abdul Hakeem; Konstantinos Toutouzas; Massoud A Leesar; Cindy L Grines; Konstantinos Marmagkiolis
Journal:  Circulation       Date:  2016-03-29       Impact factor: 29.690

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.